Immunopharmacological indices of piroxicam
Giełdanowski, J.; Kowalczyk-Bronisz, S.H.; Błaszczyk, B.
Archivum Immunologiae et Therapiae Experimentalis 38(3-4): 239-247
1990
ISSN/ISBN: 0004-069X PMID: 2151707 Document Number: 355015
The activity of piroxicam to the selected cellular immune reactions was studied. The drug was shown to modulate these processes, with the prevailing role of suppressive component. It was found that the mechanism of its effect partly consists in an interference in the activity of suppressor cells and mediators of immunological reactions.
Document emailed within 1 workday
Related Documents
Bannwart, B.; Bertin, P.; Péhourcq, F.; Schaeverbeke, T.; Gillet, P.; Lefrançois, G.; Trèves, R.; Dehais, J.; Netter, P.; Gaucher, A. 2001: Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin International Journal of Clinical Pharmacology and Therapeutics 39(1): 33-36Dolci, G.; Ripari, M.; Pacifici, L.; Umile, A. 1994: Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain International Journal of Clinical Pharmacology Research 14(5-6): 185-191
Jug, M.; Bećirević-Laćan, M.; Cetina-Cizmek, B.; Horvat, M. 2004: Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex Die Pharmazie 59(9): 686-691
Kovalev, I.E.; Rubtsova, E.R.; Podymova, N.G.; Konovalova, N.V.; Neugodova, T.P. 1986: Immunopharmacological activity of perfluorotributylamine Farmakologiia i Toksikologiia 49(2): 28-31
Dukor, P. 1978: Immunopharmacological control of inflammation Annals of the Royal College of Surgeons of England 60(3): 204-207
Ríos-Hernández, M.; Dos-Santos, N.J.; Silvia-Cardoso; Bello-Gárciga, J.L.; Pedroso, M. 1994: Immunopharmacological studies of beta-1,3-glucan Archives of Medical Research 25(2): 179-180
Urtizberea, M.; Latour, M.; Edelman, L.; Carcagne, J.; Armand, J.; Scherrmann, J.M. 1990: Immunopharmacological activity of monoclonal antidigitoxin Developments in Biological Standardization 71: 147-157
Matsuno, H.; Kitano, T.; Matsushita, I.; Tsuji, H.; Ochiai, H. 1993: Immunopharmacological evaluation of bucillamine in rheumatoid arthritis Drugs under Experimental and Clinical Research 19(5): 205-211
Florentin, I.; Chung, V.; Martinez, J.; Maral, J.; Le Garrec, Y.; Mathé, G. 1986: In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues Methods and Findings in Experimental and Clinical Pharmacology 8(2): 73-80
Rojo, J.M.; Barasoain, I.; Jorba, G.; Portolés, A. 1980: Immunopharmacological controls of indirect side-effects in antibiotherapy Archivos de Farmacologia y Toxicologia 6(2): 107-118
Yanagihara, Y.; Koda, A. 1979: Immunopharmacological study of buckwheat hypersensitivity (II). Effect of dialysate on antibody formation Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 721-730
Takeshita, K.; Fukazawa, I.; Nakaike, S.; Kameo, K.; Tomisawa, K.; Otomo, S.; Aihara, H. 1988: Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acid derivatives. II. Immunosuppressive effects Drugs under Experimental and Clinical Research 14(5): 311-318
Chanarat, P.; Chanarat, N.; Fujihara, M.; Nagumo, T. 1997: Immunopharmacological activity of polysaccharide from the pericarb of mangosteen garcinia: phagocytic intracellular killing activities Journal of the Medical Association of Thailand 80(Suppl 1): S149-S154
Kowalczyk-Bronisz, S.H.; Mojsiejewska, D.; Pomorski, J. 1991: Synthesis and immunopharmacological analysis of selected derivatives of N,N'-bis-/3-aziridine/butanoylalkylenediamines and imides of 3-aziridinesuccinic acid. i Archivum Immunologiae et Therapiae Experimentalis 39(3): 261-269
Kuz'min, S.N.; Pershin, B.B.; Medvedev, V.I.; Filatov, N.N.; Gimushina, V.D. 1994: Validation of the choice of the optimal immunopharmacological schemes for performing mass antigen-nonspecific immunoprophylactic measures Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 46-48
Pandey, B.L.; Das, P.K. 1988: Immunopharmacological studies on Picrorhiza kurroa Royle-ex-Benth. Part III: Adrenergic mechanisms of anti-inflammatory action Indian Journal of Physiology and Pharmacology 32(2): 120-125
Kowalczyk-Bronisz, S.H.; Zabska, R. 1986: Studies on the derivatives of aziridine. I. synthesis and immunopharmacological analysis of amides of alpha-aziridinyl- beta-/p-chlorobenzoyl/-propionic acid Archivum Immunologiae et Therapiae Experimentalis 34(3): 333-350
Yanagihara, Y.; Abe, T.; Kuroda, T.; Shida, T. 1988: Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 5th communication: effects on immunological reactions in mice and humans Arzneimittel-Forschung 38(1): 88-92
Zaslavskaia, R.M.; Duda, S.G.; Teĭblium, M.M.; Kon'kova, A.F.; Shekhaeva, O.M. 1983: Diurnal rhythms of indices of circulatory and catecholamine excretion indices in patients with neurocirculatory dystonia Klinicheskaia Meditsina 61(9): 89-93
Parfenov, S.B.; Ozeretskovskaia, N.N.; Pomigalov, A.I.; Chistiakova, I.V. 1989: Clinico-immunologic indices of various patient contingents in a focus of chronic opisthorchiasis. 3. Dynamics of the indices following praziquantel treatment Meditsinskaia Parazitologiia i Parazitarnye Bolezni 4: 72-75